Becton Dickinson (BDX): financials, SEC filings and peers

Becton Dickinson (BDX) is a health care equipment company in the Health Care sector of the S&P 500, headquartered in Franklin Lakes, New Jersey.

It was founded in 1897 and joined the S&P 500 on September 30, 1972.

Its fiscal year ends in September, and its shares trade on the NYSE.

In its SEC filings it is classified as “Surgical & Medical Instruments & Apparatus”.

Becton Dickinson at a glance

Revenue (12 months): $23.3B
Revenue growth: +17.4%
Operating margin: 10.7%
Net income (12 months): $941M
Free cash flow (12 months): —
Cash: $708M
Debt: $16.8B
Diluted EPS (12 months): $3.32

Twelve months to June 30, 2026, from the 10-Q filed August 6, 2026.

Latest twelve months

Over the twelve months to June 30, 2026, Becton Dickinson reported revenue of $23.3 billion, up 17.4% from a year earlier.

Its operating margin was 10.7%: for every $100 of sales, about $11 was left as operating profit.

Net income was $941 million (4.0% of revenue), 40.6% lower than a year earlier.

Profit fell while sales grew, which usually points to higher costs, heavier investment or one-time items. The filings explain which.

At the end of the period it held $708 million in cash and $16.8 billion in debt, a net debt position of $16.1 billion.

The diluted share count fell 4.2% in a year, typically the result of buybacks.

Five-year trend

Revenue went from $16.1 billion in fiscal 2020 to $21.8 billion in fiscal 2025, about 6.3% a year.
Revenue has grown for 3 fiscal years in a row.
Operating margin widened from 5.7% to 11.8% over the same years.
Free cash flow was positive in each of the last 6 fiscal years.

Fiscal year	2021	2022	2023	2024	2025
Revenue	$19.1B	$18.9B	$19.4B	$20.2B	$21.8B
Revenue growth	19.0%	-1.4%	2.7%	4.2%	8.2%
Operating margin	11.8%	12.1%	10.9%	11.9%	11.8%
Net income	$2.1B	$1.8B	$1.5B	$1.7B	$1.7B
Free cash flow	$3.5B	$1.5B	$2.1B	$3.1B	$2.7B
Diluted EPS	$6.85	$5.88	$4.94	$5.86	$5.82

Fiscal years as reported in Becton Dickinson’s 10-K filings. Free cash flow is operating cash flow minus capital spending.

Recent SEC filings

10-Q filed August 6, 2026 — quarterly report
8-K filed August 6, 2026 — Earnings results
8-K filed July 22, 2026 — Executive or director change; Regulation FD disclosure
8-K filed May 29, 2026 — Regulation FD disclosure
8-K filed May 20, 2026 — Material agreement; New debt obligation
8-K filed May 12, 2026 — Other event
10-Q filed May 7, 2026 — quarterly report
8-K/A filed May 7, 2026 — Executive or director change; Regulation FD disclosure

All Becton Dickinson filings on SEC EDGAR

Companies like Becton Dickinson

Other S&P 500 companies in Health Care Equipment:

More from Health Care

All 60 Health Care companies →

Questions about Becton Dickinson

Is Becton Dickinson's revenue growing?

Yes. Revenue for the twelve months to June 30, 2026 was $23.3 billion, up 17.4% from a year earlier, according to its SEC filings.

Is Becton Dickinson profitable?

Yes. It earned $941 million in net income over the twelve months to June 30, 2026, a net margin of 4.0%.

Does Becton Dickinson have more cash or more debt?

At June 30, 2026 it had $708 million in cash and $16.8 billion in debt, so more debt than cash.

When did Becton Dickinson last file financial results?

Its latest quarterly report (10-Q) was filed with the SEC on August 6, 2026.

Which companies are similar to Becton Dickinson?

In the S&P 500, Becton Dickinson is grouped in Health Care Equipment within the Health Care sector. Abbott Laboratories (ABT), Baxter International (BAX), Boston Scientific (BSX), Dexcom (DXCM), Edwards Lifesciences (EW) are in the same group.

Understand the numbers

Source: Becton Dickinson’s filings with the U.S. Securities and Exchange Commission (EDGAR), retrieved September 27, 2026. Figures are as reported by the company and may be restated. This page is for information only and is not financial advice.